Literatur
-
1
Karges W. et al .
Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Exp Clin Endocrinol Diabetes.
2004;
112
52-58
-
2
Vierhapper H. et al .
Routine measurement of plasma calcitonin in nodular thyroid diseases.
JCEM.
1997;
82
1589-1593
-
3
Karanikas G. et al .
Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
J Clin Endocrinol Metab.
2004;
89
515-519
-
4
Hodak S P, Burman K.
The calcitonin conundrum-is it time for routine measurement of serum calcitonin in patients with thyroid nodules?.
J Clin Endocrinol Metab.
2004;
89
511-514
-
5
Sheppard M C.
Should serum calcitonin be measured routinely in all patients with nodular thyroid disease?.
Clin Endocrinol.
1995;
42
451-452
-
6
Ortiz R. et al .
Effect of early referral to an endocrinologist on efficiency and cost of evaluation and development of treatment plan in patients with thyroid nodules.
J Clin Endocrinol Metab.
1998;
83
3803--7
-
7
Paschke R, Reiners C, Führer D, Schmid K W, Dralle H, Brabant G.
Empfehlungen und offene Fragen in der Diagnostik und Therapie von Schilddrüsenknoten.
Dtsch Med Wochenschr.
2005;
130
1831-1836
Prof. Dr. med. R. Paschke
Prof. Dr. med. H. Dralle
Prof. Dr. med. C. Reiners
Prof. Dr. med. K. W. Schmid
Prof. Dr. med. G. Brabant
Medizinische Klinik und Poliklinik III, Universität Leipzig
Philipp-Rosenthal-Straße 27
04103 Leipzig
